KR L
PI L

AC EL
CA TA

CHAPTER VII Capital Markets for Cannabis Companies

m Public Capital Markets: Canada

As of November 30, 2017, six cannabis-related companies were trading on the TSX, 20 were trading
on the TSXV and 41 were trading on the CSE. Most of the publicly traded cannabis-related companies
in Canada are licensed producers under Canada’s Access to Cannabis for Medical Purposes Regula-
tions, which allow a company to produce and sell medical cannabis products in Canada. A number of
companies traded on the CSE also have cannabis-related operations in the United States. The following
table provides a summary of cannabis-related companies traded on Canadian stock markets.

Summary of Canadian Publicly Traded Cannabis-Related Companies
(As of November 30,2017)

Number of Market Enterprise LTM LTM

Companies Value Value Cash Debt Revenue’ EBITDA
Toronto Stock Exchange (TSX) 6 $1,361.5 $1,311.4 $71.0 $20.8 $26.6 $0.8
TSX Venture Exchange (TSXV) 20 131.5 123.9 10.8 3.3 1.2 -3.5
Canadian Securities Exchange (CSE) 41 12.6 72.0 2.0 1.4 1.8 -2.8
Canada 67 $210.6 $203.3 $11.1 $3.8 $4.0 -$2.2

Source: S&P Global Market Intelligence. Companies that are traded on more than one market are included in their primary market as determined by
S&P Global Market Intelligence, based on stock price history, trading volume and availability of estimates. Enterprise Value is defined as Market
Value plus Debt minus Cash and Cash Equivalents. LTM is Last Twelve Months. EBITDA is defined as Earnings Before Interest, Taxes, Depreciation
and Amortization.

Stock Price Performance of Canadian
Publicly Traded Cannabis-Related Companies

The following chart shows the stock price performance of selected publicly traded cannabis-related
companies in Canada since September 30, 2016. The chart indicates that the stock price performance
of cannabis-related companies trading on Canadian markets received a boost from the announcement
of the proposed recreational cannabis legislation in Canada by Prime Minister Justin Trudeau and,
more recently, from Constellation Brands’ investment in Canopy Growth.

© 2017 Ackrell Capital, LLC | Member FINRA/SIPC 127

HOUSE_OVERSIGHT_024763
